Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Their mission is to save 100,000 lives and $1.5B in healthcare costs.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.
